Development of a Wearable System for the Detection of Ingestible Medication Based on Electromagnetic Waves

Author:

Hoshino Junya1,Hyry Jaakko1ORCID,Kobayashi Takumi1,Anzai Daisuke1ORCID

Affiliation:

1. Graduate School of Engineering, Nagoya Institute of Technology, Nagoya 466-8555, Japan

Abstract

Managing medication status solves related complications and prevents increases in medical costs due to the improper management of prescriptions. An ingestible sensor can be used to confirm a patient’s real-time medical status by measuring the electromagnetic waves transmitted from an ingested medication from outside of the human body. However, concerns about costs of delivery arise, as it would be necessary to attach a sensor to each ingested medication. In this study, we focused on using an electromagnetic (EM) imaging method which can estimate the internal structure of various objects using a scattered electric field. With this method we can detect medication as it does not require the installation of a sensor. At first we performed an electromagnetic field simulation and based on the results we experimentally measured the external electric field, which changes with the medicine. Then, we evaluated the accuracy of the detection method by calculating the difference between the detection rate with the proposed detection method against a more conventional method. The results indicate the possibility of achieving a more than 20% higher accuracy than the conventional detection method with our proposed method using electromagnetic waves.

Funder

JST Moonshot R&D

Publisher

MDPI AG

Reference25 articles.

1. Wang, J., and Wang, Q. (2012). Body Area Communications: Channel Modeling, Communication Systems, and EMC, John Wiley & Sons.

2. System architecture of a wireless body area sensor network for ubiquitous health monitoring;Otto;J. Mob. Multimed.,2006

3. (2012). IEEE Standard for Local and metropolitan area networks—Part 15.6: Wireless Body Area Networks. Standard No. 802.15.6-2012.

4. An ingestible sensor for measuring medication adherence;Hafezi;IEEE Trans. Biomed. Eng.,2014

5. Otsuka Pharmaceutical Co., Ltd. (2024, January 08). Otsuka and Proteus Announce the First U.S. FDA Approval of a Digital Medicine System: ABILIFY MYCITE (Aripiprazole Tablets with Sensor). Available online: https://www.otsuka.co.jp/en/company/newsreleases/2017/20171114_1.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3